Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
08:52am, Monday, 25'th Aug 2025
SECAUCUS, N.J. , Aug. 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA)
Why Is Quest Diagnostics (DGX) Up 8.2% Since Last Earnings Report?
12:31pm, Thursday, 21'st Aug 2025
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
11:16am, Thursday, 21'st Aug 2025
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
Eleventh Circuit Upholds Dismissal Of Qui Tam FCA Suit For Failure To Meet Rule 9(b) Specificity
10:15am, Tuesday, 19'th Aug 2025
OverviewIn a qui tam action filed under the False Claims Act, the relator, Barbara Senters, appealed the district court's dismissal of her fourth amended complaint (FAC), which alleged that Quest Diag
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
06:14pm, Friday, 15'th Aug 2025
SECAUCUS, N.J. , Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will spea
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
10:45am, Thursday, 14'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Declares Quarterly Cash Dividend
06:35pm, Wednesday, 13'th Aug 2025
SECAUCUS, N.J. , Aug. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash divide
Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types
09:08am, Thursday, 07'th Aug 2025
SECAUCUS, N.J. and BOSTON , Aug. 7, 2025 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with Mass General Brigham investigators a
Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care
08:33am, Tuesday, 05'th Aug 2025
SECAUCUS, N.J. , Aug. 5, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisit
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
08:52am, Tuesday, 29'th Jul 2025
New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON , July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology bus
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term
10:46am, Monday, 28'th Jul 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Raises 2025 Guidance
05:02pm, Tuesday, 22'nd Jul 2025
Diagnostic testing and information services provider Quest Diagnostics (DGX 7.04%) reported fiscal 2025 second-quarter results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 rev
Quest Diagnostics Boosts Its 2025 Outlook
02:19pm, Tuesday, 22'nd Jul 2025
Quest Diagnostics (DGX 7.16%) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year over year), organic revenue growth of 5.2%, while adju
Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks
01:10pm, Tuesday, 22'nd Jul 2025
Quest Diagnostics Inc. DGX delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.
Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript
12:22pm, Tuesday, 22'nd Jul 2025
Quest Diagnostics Incorporated (NYSE:DGX ) Q2 2025 Earnings Conference Call July 22, 2025 8:30 AM ET Company Participants James E. Davis - Chairman, CEO & President Sam A.
